INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

期刊官网投稿通道

提出问题

友情提示：以下期刊信息可能会有更新，仅供参考，请在投稿前自行登录期刊官网仔细核实。

期刊名

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

INT J IMMUNOPATH PH

ISSN / eISSN

0394-6320 / 2058-7384

目标和范围

International Journal of Immunopathology and Pharmacology is an Open Access peer-reviewed journal publishing original papers describing research in the fields of immunology, pathology and pharmacology. The intention is that the journal should reflect both the experimental and clinical aspects of immunology as well as advances in the understanding of the pathology and pharmacology of the immune system.

研究方向

病理学

药学

免疫学

CiteScore

3.40

查看趋势图

CiteScore 学科排名

类别	分区	排名
Pharmacology, Toxicology and Pharmaceutics - Pharmacology	Q3	#183/301
Pharmacology, Toxicology and Pharmaceutics - Immunology and Allergy	Q3	#144/211
Pharmacology, Toxicology and Pharmaceutics - Immunology	Q3	#162/217

Web of Science 核心合集

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

类别 (Journal Citation Reports 2023)	分区
IMMUNOLOGY - SCIE	Q3
PATHOLOGY - SCIE	Q2
PHARMACOLOGY & PHARMACY - SCIE	Q2

H-index

出版国家或地区

ITALY

出版商

SAGE Publications Inc.

出版周期

Quarterly

出版年份

1988

年文章数

Open Access

YES

通讯方式

BIOLIFE SAS, VIA S STEFANO 39 BIS, SILVA MARINA (TE), ITALY, 64029

同领域相关热门期刊
近期发表文章

Novel anti-amyloid-beta (Aβ) monoclonal antibody lecanemab for Alzheimer’s disease: A systematic review: (2023) Selia Chowdhury, Nurjahan Shipa Chowdhury

Inhibition of GPR30 sensitized gefitinib to NSCLC cells via regulation of epithelial-mesenchymal transition: (2023) Xiaomin Yang, Hongyan Jiang, Jiang Ning, Shufen Zhang, Ying Cai, Liang Wang, Jinsong Yang, Guodong Xu, Wei Chen, Jianfei Wang

Analysis of mitochondrial function in lymphocytes obtained from COVID-19 patients: (2023) Zhi He, Jing-Jing Liu, Shao-Lei Ma

PKNOX1 acts as a transcription factor of DHH and promotes the progression of stomach adenocarcinoma by regulating the Hedgehog signalling pathway: (2023) Bing Liu, Siwei Zhao, Liqing Liu

The impact of hepatitis B virus and hepatitis C virus infections in patients with Hodgkin's and non-Hodgkin’s lymphoma: (2023) Dalia Y Kadry, Mostafa A Elbahnasawy, Mohamed TM Mansour, Omnia K EL Gebaly, Hala Aziz, Mahmoud M Kamel, Ahmed S Abdel-Moneim, Samah Radwan

Association of cerebrospinal fluid CD4+/CD8+Ratio with 60-day functional outcome after intracerebral hemorrhage: (2023) Chunying Zhu, Wei Li, Yingfu Zhang, Qianqian Li, Huan Wang

Revolutionizing antiretroviral therapy for human immunodeficiency virus/AIDS: A computational approach using molecular docking, virtual screening, and 3D pharmacophore building to address therapeutic failure and propose highly effective candidates: (2023) Azzeddine Annan, Noureddine Raiss, El Harti Elmir, Abdelkarim Filali-Maltouf, Leila Medraoui, Hicham Oumzil

Follow the time course of inflammation caused by intraperitoneal administration of multi-wall carbon nanotubes in mice: (2023) Masanori Horie, Sakiko Sugino, Tomoki Ohno

Prognostic and immunological role of acetaldehyde dehydrogenase 1B1 in human tumors: A pan-cancer analysis: (2023) Yong Kuang, Jiahao Feng, Yuhong Jiang, Qianqian Jin, Qi Wang, Changhua Zhang, Yulong He

METTL3-mediated m6A modification of lncRNA SNHG3 accelerates gastric cancer progression by modulating miR-186-5p/cyclinD2 axis: (2023) Guo Ji, Xiu Wang, Hao Xi

认证评论

注：认证评论选取于全球各个学术评论平台和社交媒体。

One of our classmates in the laboratory received a solicitation from the editor of this magazine in December. Coincidentally, he had an article at hand, so he made some modifications and submitted it. The magazine responded quite quickly as the next day, the article on their official website changed from "editorial solicitation" to "peer review." Ten days later, we received a rejection letter stating that the magazine had received many submissions and our overall article quality was not high. Hmm... This magazine was on the warning list in January 2020 but came off the list in December. This may be a result of their strict and high requirements.

2022-01-13

查看所有评论

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started